tianjin tianyao pharmaceuticals announced that its subsidiary tianjin tianyao heping (tianjin) pharmaceuticals co., ltd. received the pharmaceutical registration certificate for betamethasone phosphate injection approved and issued by the national medical products administration. This pharmaceutical is primarily used for allergic and autoimmune inflammatory diseases, such as active rheumatoid disease, rheumatoid arthritis, lupus erythematosus, etc.
津药药业：子公司津药和平获得倍他米松磷酸钠注射液药品注册证书
tianjin tianyao pharmaceuticals: The subsidiary tianjin tianyao heping has obtained the pharmaceutical registration certificate for betamethasone phosphate injection.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney